Skip to content

STERIS STE Total Equity

Total Equity at other companies

Baxter International logo
Baxter InternationalBAX
$6.04B-14.7%
Ecolab logo
EcolabECL
$10B+12.7%
3M logo
3MMMM
$3.26B-26.9%
Mesa Laboratories logo
Mesa LaboratoriesMLAB
$186.25M+16.5%
Boston Scientific logo
Boston ScientificBSX
$25.86B+16.4%
IAR
Integra LifeSciencesIART
$1.04B-31.6%

Other financials

Income statement

See full
Revenue$1.6B+7.3%
Gross profit$697.2M+8.8%
Operating income$316.8M+46.6%
Net income$220.2M+51.2%
EPS (diluted)$2.24+52.4%

Balance sheet

See full
Cash & equivalents$439.6M+156%
Total debt$2.1B-10.3%
Total assets$10.7B+5.8%

Cash flow

See full
Operating cash flow$335.4M+28.6%
CapEx$90.2M+27.2%
Free cash flow$245.2M+29.1%

Valuation

See full
Market cap$20.52B-9.4%
Enterprise value$22.17B-8.8%
P/E26.2×-8.8×
P/S3.5×-0.6×

Profitability

See full
Gross margin44.2%+0.2pp
Operating margin18.6%+2.7pp
Net margin13.2%+1.9pp
FCF margin16.4%+2.1pp

Returns & leverage

See full
Return on equity11.3%+1.8pp
Debt / equity0.3×-0.1×
Current ratio2.1×+0.1×

Where this comes from

Reported directly by STERIS in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: STERIS’s 10-K, filed May 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about STERIS's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is STERIS's total equity?
STERIS (STE) reported total equity of $7.18B in Q1 2026.
How has STERIS's total equity changed year-over-year?
STERIS's total equity increased by 8.8% year-over-year, from $6.6B to $7.18B.
What is the long-term trend for STERIS's total equity?
Over 5 years (2021 to 2026), STERIS's total equity has grown at a 13.1% compound annual growth rate (CAGR), from $3.88B to $7.18B.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.